Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.24 USD | -0.04% |
|
+0.52% | -0.28% |
25/06 | Biotech Firm Clario Eyes IPO Early in 2025 | MT |
25/06 | Sector Update: Financial Stocks Fall Late Afternoon | MT |
Strengths
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Sales forecast by analysts have been recently revised upwards.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's earnings growth outlook lacks momentum and is a weakness.
Ratings chart - Surperformance
Sector: Banks
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.28% | 57TCr | - | ||
+16.96% | 31TCr | C+ | ||
+19.90% | 26TCr | C+ | ||
+24.73% | 19TCr | B- | ||
+28.86% | 17TCr | B- | ||
+8.10% | 16TCr | C+ | ||
+0.12% | 15TCr | B- | ||
+8.39% | 15TCr | B- | ||
+14.30% | 14TCr | C+ | ||
+23.29% | 12TCr | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- JPM Stock
- JPM.PRC Stock
- Ratings JPMorgan Chase & Co.